Table 1 Epidemiological and clinical characteristics of patients with low versus high Rankin Scores at the final of the follow up

N (%)

51 (60)

34 (40)

85

Age, mean (SD), y

38.9 (14)

49 (17.7)

0.005

43 (16.2)

Sex, male/female

21/30

19/15

0.194

40/45

Follow up, median (IQR), y

2.9 (1.5-4.1)

2.7 (0.3-7.4)

0.683

2.9 (1–4.8)

Time to maximum deficit, mean (SD), d

7.2 (7)

6.91 (7.6)

0.821

7.1 (7.1)

Admission Rankin Mean (SD)

2.27 (1)

3.65 (1.1)

<0.001 ^a

2.82 (1.2)

Outcome Rankin Mean (SD)

____

____

____

1.4 (1.3)

Time onset-start treatment, mean (SD), d

9.7 (8.3)

8.5 (8)

0.602

9.2 (8.1)

Back pain, n (%)

19 (37.3)

16 (47.1)

0.380

35 (41.2)

Urinary sphincter dysfunction, n (%)

21 (41.2)

26 (76.5)

0.001 ^a

47 (55.3)

Anal sphincter dysfunction, n (%)

2 (4)

9 (26.5)

0.002

11 (13)

Previous infection, n (%)

19 (37.3)

8 (23.5)

0.237

27 (31.8)

Summer season/Not summer season, n (%)

9/49 (18) /40/49 (81.6)

5/34 (14.7) / 29/34 (85.3)

0.661

14 (16.47) /69 (81.17)

TM relapses, n (%)

5/51 (9.8)

0/33 (0)

0.085

5/84 (6)

MS conversion, n (%)

8 (15.7)

3 (8.8)

0.513

11 (13)